TAVR, baroreflex activation for heart failure, dapagliflozin for
HF, and myocardial viability are the topics discussed by John
Mandrola in this week’s podcast.
This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.